Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation
The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease
Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients
Fabry Disease in Cerebrovascular Disease
Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis
† Study has passed its completion date and status has not been verified in more than two years.